Avalo Therapeutics, Inc. Common Stock (AVTX)
PHARMACEUTICAL PREPARATIONS
Avalo Therapeutics, Inc. Common Stock (AVTX) is listed on Nasdaq, where it has traded since November 13, 2015.
- Listed On
- Nasdaq
- Listed Since
- November 13, 2015
- Employees
- 33
- Market Cap
- $382M
About Avalo Therapeutics, Inc. Common Stock
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 124 institutions reported holding AVTX, with 70.8 million shares worth $1.3 billion in aggregate. The largest reported holder was FMR, with 5.1 million shares worth $94.3 million. Of the 5 largest holders listed below, 1 opened a new position in AVTX and 4 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| FMR | 5,100,216 | $94M | Added 77.12% |
| BlackRock | 4,365,553 | $81M | Added 1234.7% |
| Deep Track Capital | 3,610,000 | $67M | New position |
| Caligan Partners | 3,163,866 | $58M | Added 93.51% |
| Tcg Crossover Management | 3,017,120 | $56M | Added 308.61% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AVTX?
Avalo Therapeutics, Inc. Common Stock (AVTX) is listed on Nasdaq, where it has traded since November 13, 2015.
Who are the largest institutional holders of AVTX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AVTX were FMR, BlackRock and Deep Track Capital.
How many institutions own AVTX?
124 institutions reported a position in AVTX for the quarter ended June 30, 2026, worth $1.3 billion in total.
Did institutions buy or sell AVTX last quarter?
Of the 5 largest reported holders, 1 opened a new position in AVTX and 4 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for AVTX.
Every reported institutional holder, plus insider and congressional trades in AVTX, on SentiSense.